RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
1-Year Return
33.9%
This Quarter Return
+9.5%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.76B
AUM Growth
+$16.7M
(+0.96%)
Cap. Flow
-$86M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
275
New
15
Increased
54
Reduced
181
Closed
13
Top Buys
| 1 |
Pacira BioSciences
PCRX
|
$12.5M |
| 2 |
RB Global
RBA
|
$11.7M |
| 3 |
Doximity
DOCS
|
$8M |
| 4 |
Establishment Labs
ESTA
|
$6.2M |
| 5 |
Columbia Banking Systems
COLB
|
$3.86M |
Top Sells
| 1 |
IAA
IAA, Inc. Common Stock
IAA
|
$17.7M |
| 2 |
Medifast
MED
|
$16.1M |
| 3 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$11.1M |
| 4 |
WNS Holdings
WNS
|
$6.38M |
| 5 |
iShares Russell 2000 Growth ETF
IWO
|
$6.06M |
Sector Composition
| 1 | Healthcare | 27.26% |
| 2 | Technology | 26.78% |
| 3 | Industrials | 17.12% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Guaranty Bancshares
GNTY
$560M
| $1.27M | 0.07% |
45,512
-32,086
| -41% | -$894K |
|
227
MP Materials
MP
$11B
| $1.27M | 0.07% |
44,932
+2,218
| +5% | +$62.5K |
|
228
Devon Energy
DVN
$21.9B
| $1.26M | 0.07% |
24,940
-286
| -1% | -$14.5K |
|
229
Mirum Pharmaceuticals
MIRM
$3.81B
| $1.26M | 0.07% |
+52,295
| New | +$1.26M |
|
230
Puma Biotechnology
PBYI
$258M
| $1.14M | 0.06% |
367,497
-15,721
| -4% | -$48.6K |
|
231
Glacier Bancorp
GBCI
$5.86B
| $1.12M | 0.06% |
26,671
+354
| +1% | +$14.9K |
|
232
Trade Desk
TTD
$25.4B
| $1.09M | 0.06% |
17,946
-123
| -0.7% | -$7.49K |
|
233
Teledyne Technologies
TDY
$25.6B
| $1.05M | 0.06% |
2,339
-19
| -0.8% | -$8.5K |
|
234
Columbia Sportswear
COLM
$3.16B
| $1.02M | 0.06% |
11,313
-149
| -1% | -$13.4K |
|
235
Berkshire Hathaway Class B
BRK.B
$1.08T
| $912K | 0.05% |
2,955
| – | – |
|
236
Denny's
DENN
$245M
| $850K | 0.05% |
76,187
+413
| +0.5% | +$4.61K |
|
237
Smith-Midland
SMID
$222M
| $794K | 0.05% |
42,329
+159
| +0.4% | +$2.98K |
|
238
AbbVie
ABBV
$376B
| $791K | 0.04% |
4,961
-20
| -0.4% | -$3.19K |
|
239
Eli Lilly
LLY
$654B
| $683K | 0.04% |
1,990
-150
| -7% | -$51.5K |
|
240
UroGen Pharma
URGN
$882M
| $676K | 0.04% |
73,205
+274
| +0.4% | +$2.53K |
|
241
Inotiv
NOTV
$55.7M
| $643K | 0.04% |
148,454
+8,695
| +6% | +$37.6K |
|
242
Chevron
CVX
$312B
| $610K | 0.03% |
3,737
| – | – |
|
243
Abbott
ABT
$233B
| $545K | 0.03% |
5,386
| – | – |
|
|
244
Berkshire Hathaway Class A
BRK.A
$1.08T
| $466K | 0.03% |
1
| – | – |
|
245
Apple
AAPL
$3.56T
| $462K | 0.03% |
2,800
| – | – |
|
246
Y-mAbs Therapeutics
YMAB
$389M
| $448K | 0.03% |
89,480
+2,390
| +3% | +$12K |
|
247
Sysco
SYY
$39.3B
| $440K | 0.03% |
5,702
-25
| -0.4% | -$1.93K |
|
248
Jacobs Solutions
J
$17.2B
| $417K | 0.02% |
4,286
| – | – |
|
249
Exxon Mobil
XOM
$470B
| $410K | 0.02% |
3,743
-460
| -11% | -$50.4K |
|
250
Walmart
WMT
$797B
| $397K | 0.02% |
8,073
| – | – |
|